We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Sempra, Prevail and Sprouts Farmers
Read MoreHide Full Article
For Immediate Release
Chicago, IL – May 11, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Sempra Energy (SRE - Free Report) , Prevail Therapeutics and Sprouts Farmers Market (SFM - Free Report) .
There are a variety of facets to the world’s COVID19 battle scenes. Take them all in at the same time to see most clearly where COVID19 matters stand.
(1) On May 1st, Cambridge, MA-based biotech Moderna announced an agreement with Swiss drug maker Lonza Group to manufacture up to a billion doses per year of mRNA-1273, Moderna's vaccine candidate for the novel coronavirus.
The two companies initially plan to establish manufacturing capabilities at Lonza's facilities in the U.S. and Switzerland to make the vaccine at both locations, with additional production suites to be established across Lonza's worldwide facilities under a 10-year agreement.
The companies expect to produce the first batches of mRNA-1273 at Lonza's U.S. facility in July 2020.
A portion of the funding for the manufacturing operations in the U.S. will come from Moderna's contract with Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services.
(2) Sir John Bell, the Regius Professor of Medicine at Oxford University, said on Sunday May 3rd that researchers at that major U.K. university — who are working on a potential vaccine for the coronavirus — would likely have an idea of its efficacy by June.
The Oxford researchers hope to generate enough data from Phase Two trials to get evidence that the vaccine has efficacy by the beginning of June.
Bell called the chances of success in developing a vaccine “pretty good,” adding “We are gradually reeling it in, bit by bit and as every day goes by, the likelihood of success goes up.”
(3) COVID-19 shutdowns are still in place, but many European countries are getting ready to test post-lockdown life.
· Italian factories and building sites reopen from Monday May 4th, after Europe’s longest lockdown
· So will German schools, museums and churches, following the reopening of small shops
· Britain will lay out its exit strategy in the first weeks of May
Slowly does it seem to be the message coming from European governments wary of a renewed spike in infections.
But with the ECB predicting the euro-area economy to shrink by as much as 15% in Q1, the authorities are also keen to get activity going again. The authorities will watch April trade and industrial output data for clues on how Q2 might shape up.
The stricken country of Italy faces a sovereign bond rating review from Moody’s on Friday May 8th. At a notch above junk, the rating is very likely safe. An unexpected downgrade from Fitch would jangle nerves.
(4) After two months of intensive social distancing, South Korea is about to open up too.
According to the Wall Street Journal, South Korea has a rule for everything.
When meeting in an office, people will wear masks. At meals, diners will sit next to each other or in a zigzag pattern, not directly across. Hotel rooms will be ventilated for 15 minutes after travelers check out. Visitors at zoos and aquariums must stand 6 feet apart. Shouting and hugging will be discouraged at sporting events. So will high-fives.
(5) In China, their enormous and globally-connected industrial sector probably comes back to life before the more domestic services side.
China’s policymakers appear cautious about allowing service businesses such as movie theaters and gyms to reopen.
That means that there’s still some way to go before that country returns to a situation that’s close to “normal.”
(6) The operating capacity of Brazilian industry dropped to 57.5% in April, the lowest in a time series going back to January 2001.
While the Brazilian industry overall is using just over half of its productive capacity, the impact varies among sectors:
· Car manufacturers have been hit the hardest, using only 12.5% of their overall capacity
· Other areas, such as apparel and leather goods & shoes are down to 20.5% and 24.5%, respectively
· On the other hand, paper & pulp manufacturing is the positive highlight, with 90% of its capacity in use
On May 4th, the city of Sao Paulo (Brazil’s biggest metro area) began blocking major avenues, aiming at reducing the number of people breaking social isolation.
(7) The Russian National Guard said it is using drones and a helicopter to enforce self-isolation rules in Moscow and the Moscow region over that country’s May holidays.
The drones and helicopter will send information about violations to officers on the ground, who will then issue fines to violators.
(8) Despite grim virus statistics, India allowed most businesses and services to reopen on Monday May 4th, entering a third phase in the national lockdown strategy. Indians were warned it was time to learn to "live with the virus."
(9) Japan's prime minister extended a state of emergency over the corona virus until the end of May. That government warned it was too soon to lift restrictions.
Zacks May Sector/Industry/Company Telescope
The Zacks Industry Rank pattern in Early May is very “Stay-at-Home” directive driven.
As May to June leads to more reopened sectors, in more and more big U.S. states, this ranking may be dated. Be careful this month.
The best groups are Utilities, Health Care, and Staples. Those are the obvious “Stay-at-Home” plays.
Info Tech and Communication Services retain some status, and also imply “Stay-at-Home” plays. Drugs are a top-notch area, as COVID19 vaccines, treatments, and frankly stable dividends make the group tops.
Financials Energy and Industrials feel the most stress. But Investment Funds stunningly outperform. Alternates in Energy can be held at Market Weight.
(1) Utilities went back to Very Attractive. Utilities-Gas Distribution looks excellent. Electric Power is looking good.
Zacks #2 Rank (BUY): Sempra Energy
Sempra Energy is a southern California-based energy services holding company involved in the sale, distribution, storage and transportation of electricity and natural gas.
The company has recently reorganized its subsidiaries under two operating groups: Sempra Utilities and Sempra Infrastructure.
The Sempra Utilities group includes the company’s utility operations: Southern California Gas Co. (SoCalGas), San Diego Gas & Electric (SDG&E) and Sempra South American Utilities.
(2) Health Careis Attractive. Only Drugs lead now, and by a wide margin.
Zacks #1 Rank (STRONG BUY): Prevail Therapeutics
Prevail Therapeutics is a gene therapy company. It focuses on developing and commercializing disease-modifying AAV-based gene therapies for patients with devastating neurodegenerative diseases.
The company's product candidate consists of PR001, PR006 and PR004 which are in clinical stage.
Prevail Therapeutics is based in New York.
(3) Consumer Staplesrise to Attractive. Cons. Products Misc. Staples and Food/Drug Retail are the strongest industry groups. That makes shut-in sense.
Sprouts Farmers Market operates in a highly fragmented grocery store industry. But it has a unique model that features fresh produce at the center of the store, an expansive bulk foods section, and a vitamin department focused on overall wellness.
Moreover, the company has been diversifying its offerings to meet changing preferences of consumers, who are looking for more health and wellness products.
(4) Info Techremains a Market Weight. Semis are best, followed by Computer- Software Services.
(5) Communications Servicesis Market Weight. Telco Equipment and Telco Services are about equal now. Utility-Telephone still looks poor.
(6) Materialsare Market Weight. What helped? Same as last month. Containers & Glass (packaged goods in grocery stores) look good. Ditto Metals Non-ferrous (gold).
(7) Consumer Discretionaryis Very Unattractive. The Other Consumer Discretionary group is all that looks good. Lots of poor industry groups here.
(8) Financials stay Very Unattractive. Investment Funds look best.
(9) Energyremains Very Unattractive. But Bifurcated. Coal, Drillers, and Alternates are OK.
(10) Industrialsremains Very Unattractive. CEOs are pessimistic. Conglomerates are the sole spot above a Market Weight.
Conclusion
We are now observing a staggered opening of economies, both stateside and abroad.
Carry on with substantial, regularly-spaced, equity market asset allocations. This is an event-driven regime. The Fed and the other major central banks of the world have share buyer’s backs.
Prices on the most respected stocks are still oftentimes better than six or eight months ago. But be ready to see core elements of a worst-case scenario materialize. The return of shutdowns in selected places can create stock market volatility again.
Just Released: 5 Stocks Set to Double
Four Zacks experts each announce their single favorite pick with potential to gain +100% and more in the months ahead. Today, download the private Special Report that names these stocks and spotlights why their upside is so exceptional.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Sempra, Prevail and Sprouts Farmers
For Immediate Release
Chicago, IL – May 11, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Sempra Energy (SRE - Free Report) , Prevail Therapeutics and Sprouts Farmers Market (SFM - Free Report) .
Here are highlights from Friday’s Analyst Blog:
The World vs. a Virus: Zacks May Strategy
The following is an excerpt from Zacks Chief Strategist John Blank’s full May Market Strategy reportTo access the full PDF, click here
There are a variety of facets to the world’s COVID19 battle scenes. Take them all in at the same time to see most clearly where COVID19 matters stand.
(1) On May 1st, Cambridge, MA-based biotech Moderna announced an agreement with Swiss drug maker Lonza Group to manufacture up to a billion doses per year of mRNA-1273, Moderna's vaccine candidate for the novel coronavirus.
The two companies initially plan to establish manufacturing capabilities at Lonza's facilities in the U.S. and Switzerland to make the vaccine at both locations, with additional production suites to be established across Lonza's worldwide facilities under a 10-year agreement.
The companies expect to produce the first batches of mRNA-1273 at Lonza's U.S. facility in July 2020.
A portion of the funding for the manufacturing operations in the U.S. will come from Moderna's contract with Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services.
(2) Sir John Bell, the Regius Professor of Medicine at Oxford University, said on Sunday May 3rd that researchers at that major U.K. university — who are working on a potential vaccine for the coronavirus — would likely have an idea of its efficacy by June.
The Oxford researchers hope to generate enough data from Phase Two trials to get evidence that the vaccine has efficacy by the beginning of June.
Bell called the chances of success in developing a vaccine “pretty good,” adding “We are gradually reeling it in, bit by bit and as every day goes by, the likelihood of success goes up.”
(3) COVID-19 shutdowns are still in place, but many European countries are getting ready to test post-lockdown life.
· Italian factories and building sites reopen from Monday May 4th, after Europe’s longest lockdown
· So will German schools, museums and churches, following the reopening of small shops
· Britain will lay out its exit strategy in the first weeks of May
Slowly does it seem to be the message coming from European governments wary of a renewed spike in infections.
But with the ECB predicting the euro-area economy to shrink by as much as 15% in Q1, the authorities are also keen to get activity going again. The authorities will watch April trade and industrial output data for clues on how Q2 might shape up.
The stricken country of Italy faces a sovereign bond rating review from Moody’s on Friday May 8th. At a notch above junk, the rating is very likely safe. An unexpected downgrade from Fitch would jangle nerves.
(4) After two months of intensive social distancing, South Korea is about to open up too.
According to the Wall Street Journal, South Korea has a rule for everything.
When meeting in an office, people will wear masks. At meals, diners will sit next to each other or in a zigzag pattern, not directly across. Hotel rooms will be ventilated for 15 minutes after travelers check out. Visitors at zoos and aquariums must stand 6 feet apart. Shouting and hugging will be discouraged at sporting events. So will high-fives.
(5) In China, their enormous and globally-connected industrial sector probably comes back to life before the more domestic services side.
China’s policymakers appear cautious about allowing service businesses such as movie theaters and gyms to reopen.
That means that there’s still some way to go before that country returns to a situation that’s close to “normal.”
(6) The operating capacity of Brazilian industry dropped to 57.5% in April, the lowest in a time series going back to January 2001.
While the Brazilian industry overall is using just over half of its productive capacity, the impact varies among sectors:
· Car manufacturers have been hit the hardest, using only 12.5% of their overall capacity
· Other areas, such as apparel and leather goods & shoes are down to 20.5% and 24.5%, respectively
· On the other hand, paper & pulp manufacturing is the positive highlight, with 90% of its capacity in use
On May 4th, the city of Sao Paulo (Brazil’s biggest metro area) began blocking major avenues, aiming at reducing the number of people breaking social isolation.
(7) The Russian National Guard said it is using drones and a helicopter to enforce self-isolation rules in Moscow and the Moscow region over that country’s May holidays.
The drones and helicopter will send information about violations to officers on the ground, who will then issue fines to violators.
(8) Despite grim virus statistics, India allowed most businesses and services to reopen on Monday May 4th, entering a third phase in the national lockdown strategy.
Indians were warned it was time to learn to "live with the virus."
(9) Japan's prime minister extended a state of emergency over the corona virus until the end of May. That government warned it was too soon to lift restrictions.
Zacks May Sector/Industry/Company Telescope
The Zacks Industry Rank pattern in Early May is very “Stay-at-Home” directive driven.
As May to June leads to more reopened sectors, in more and more big U.S. states, this ranking may be dated. Be careful this month.
The best groups are Utilities, Health Care, and Staples. Those are the obvious “Stay-at-Home” plays.
Info Tech and Communication Services retain some status, and also imply “Stay-at-Home” plays. Drugs are a top-notch area, as COVID19 vaccines, treatments, and frankly stable dividends make the group tops.
Financials Energy and Industrials feel the most stress. But Investment Funds stunningly outperform. Alternates in Energy can be held at Market Weight.
(1) Utilities went back to Very Attractive. Utilities-Gas Distribution looks excellent. Electric Power is looking good.
Zacks #2 Rank (BUY): Sempra Energy
Sempra Energy is a southern California-based energy services holding company involved in the sale, distribution, storage and transportation of electricity and natural gas.
The company has recently reorganized its subsidiaries under two operating groups: Sempra Utilities and Sempra Infrastructure.
The Sempra Utilities group includes the company’s utility operations: Southern California Gas Co. (SoCalGas), San Diego Gas & Electric (SDG&E) and Sempra South American Utilities.
(2) Health Careis Attractive. Only Drugs lead now, and by a wide margin.
Zacks #1 Rank (STRONG BUY): Prevail Therapeutics
Prevail Therapeutics is a gene therapy company. It focuses on developing and commercializing disease-modifying AAV-based gene therapies for patients with devastating neurodegenerative diseases.
The company's product candidate consists of PR001, PR006 and PR004 which are in clinical stage.
Prevail Therapeutics is based in New York.
(3) Consumer Staplesrise to Attractive. Cons. Products Misc. Staples and Food/Drug Retail are the strongest industry groups. That makes shut-in sense.
Zacks #1 Rank (STRONG BUY): Sprouts Farmers Market
Sprouts Farmers Market operates in a highly fragmented grocery store industry. But it has a unique model that features fresh produce at the center of the store, an expansive bulk foods section, and a vitamin department focused on overall wellness.
Moreover, the company has been diversifying its offerings to meet changing preferences of consumers, who are looking for more health and wellness products.
(4) Info Techremains a Market Weight. Semis are best, followed by Computer- Software Services.
(5) Communications Servicesis Market Weight. Telco Equipment and Telco Services are about equal now. Utility-Telephone still looks poor.
(6) Materialsare Market Weight. What helped? Same as last month. Containers & Glass (packaged goods in grocery stores) look good. Ditto Metals Non-ferrous (gold).
(7) Consumer Discretionaryis Very Unattractive. The Other Consumer Discretionary group is all that looks good. Lots of poor industry groups here.
(8) Financials stay Very Unattractive. Investment Funds look best.
(9) Energyremains Very Unattractive. But Bifurcated. Coal, Drillers, and Alternates are OK.
(10) Industrialsremains Very Unattractive. CEOs are pessimistic. Conglomerates are the sole spot above a Market Weight.
Conclusion
We are now observing a staggered opening of economies, both stateside and abroad.
Carry on with substantial, regularly-spaced, equity market asset allocations. This is an event-driven regime. The Fed and the other major central banks of the world have share buyer’s backs.
Prices on the most respected stocks are still oftentimes better than six or eight months ago. But be ready to see core elements of a worst-case scenario materialize. The return of shutdowns in selected places can create stock market volatility again.
Just Released: 5 Stocks Set to Double
Four Zacks experts each announce their single favorite pick with potential to gain +100% and more in the months ahead. Today, download the private Special Report that names these stocks and spotlights why their upside is so exceptional.
See Stocks Now >>
Join us on Facbook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancefor information about the performance numbers displayed in this press release.